China Modern Releases Net Income Guidance China Modern

New Post Public Reply Private Reply Replies (0) Message Board
SmallCapVoice

China Modern Releases Net Income Guidance

China Modern Releases Net Income Guidance of $5 Million or $0.10 EPS for the First Quarter of the Fiscal Year 2013

HARBIN, CHINA — (Marketwire) — 10/29/12 — China Modern Agricultural Information Inc. (“the Company”, “China Modern”) (OTCBB: CMCI ), a high-tech livestock company specializing in the breeding of cows and calves, the production and sale of milk and the sale of organic fertilizer, today announced net income guidance of $ 5 million or earnings per share of $0.10 based on 53.1 million fully diluted shares outstanding for the 2013 fiscal first quarter ending September 30, 2012.

The Projected Earnings of the First Quarter of 2013 Fiscal year
The projected revenue for the three months ended September 30, 2012 is expected to be $10.9 million, an increase of 119% compared with $4.98 million for the same period of last year. The revenue is primarily generated from the sales of natural milk and natural milk sales commission from farmers to which China Modern sold cows. The revenue from natural milk selling and the sales commission from farmers are forecasted to be $7.7 million and $3.3 million, respectively. The gross profit is projected to be increased by $3.7 million or 110% to approximate $7.0 million. The projected net income is $5 million, an increase of about $2.4 million or 93%, compared to the same period of last year. The projected net profit margin will be increased to 46%.

Cautionary Statement Regarding Forward Looking Information
Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our 8K/A dated March 31, 2011, and other recent filings. These filings are available at http://www.sec.gov/.

Company Contact:
Wang Youliang
CEO
Email Contact

For SmallCapVoice.com
Stuart T. Smith
512-267-2430
Email Contact
www.SmallCapVoice.com

China Modern Agricultural Information Inc (CMCI) Stock Research Links

CMCI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripple Banking License: Unlocking New Opportunities for XRP

Updated Category News Views 129

Ripple Banking License: Unlocking New Opportunities for XRP In recent developments, Ripple is on the brink of obtaining a banking license, a significant milestone that promises to reshape its role within the traditional financial sector. This pivotal moment not only ratifies Ripple’s credibility but also enhances the use of XRP among its holders. The acquisition of a...

Continue Reading
SEI's Dividend: $0.52 a Share May 2026 Call

Updated Category News Views 22

SEI's Dividends Sweeten the Pot In a world where every market shift feels like someone moving your chair just as you sit down, SEI Investments (NASDAQ: SEIC) keeps a consistent beat. They've declared a semi-annual dividend of $0.52 per share, and let me tell you, that's music to any income-seeking investor's ears right now. Those looking for steady returns in this...

Continue Reading
Solana Experiences a Significant Price Surge of 6.18%

Updated Category News Views 48

Solana price jumps 6.18% to $134.95 Solana added 6.18% in the latest session, bringing the price to $134.95. The move points to firm trading momentum as the market keeps a close eye on SOL. Gains like this usually appear when interest broadens and activity picks up, even if the day-to-day path isn’t perfectly smooth. One-week trend: steady gains from $130.33 Beyond the...

Continue Reading
BD Strengthens Future Plans with Strategic Business Separation

Updated Category News Views 1181

BD Announces Strategic Separation of Business Units BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has taken a bold step by announcing a plan to separate its Biosciences and Diagnostics Solutions divisions from the rest of the organization. This strategic separation aims to enhance focus, drive growth, and unlock substantial...

Continue Reading
Understanding Solana's Recent Price Decline and Market Impact

Updated Category News Views 273

Analyzing Solana's Price Drop In the last day, Solana has encountered a significant decrease in its price, falling by more than 9% and currently valued at $120.87. This price drop is part of a broader downward trend observed over the past week, where the cryptocurrency recorded a staggering loss of 22%. The decline in value from $157.77 to its present figure illustrates...

Continue Reading